5LX-31434-36505
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 701 / LA
- Registered
- 2021-07-26
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-26
Registered in v-safe
-
2021-07-26
Dose 1 — Pfizer-BioNTech
- 2021-07-27
- 2021-07-28
-
2021-07-29
Survey response — days 1–6 daily, dose 1MedDRA: Nasal congestion, Oropharyngeal pain — Feeling: FairFree text: Sore throat, stuffy noseMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-07-30
- 2021-07-31
- 2021-08-01
- 2021-08-02
- 2021-08-09
-
2021-08-18
Dose 2 — Pfizer-BioNTech
- 2021-08-23
- 2021-08-24
- 2021-08-25
- 2021-09-08
- 2021-09-15
- 2021-09-29
- 2021-11-17
- 2022-02-16
- 2022-08-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-26 | Pfizer-BioNTech | No |
| 2 | 2021-08-18 | Pfizer-BioNTech | No |
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Sore throat, stuffy nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Nasal congestion | ✓ | · | ✓ |
| SRO | Oropharyngeal pain | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release